1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Optional) (PA-20-272) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). These administrative supplements are intended to increase the diversity of the research workforce by supporting individuals from underrepresented groups.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Expired PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) This notice has expired. Check the NIH Guide for active opportunities and notices. Department of Health and Human Services Part 1.
Overview Information Participating Organization(s) Institutes of Health ( NIH ) National Institute for Occupational Safety and of Participating Organizations National Cancer Institute ( NCI ) National Eye Institute ( NEI ) National Heart, Lung, and Blood Institute ( NHLBI ) National Human Genome Research Institute ( NHGRI ) National Institute on Aging ( NIA ) National Institute on Alcohol Abuse and Alcoholism ( NIAAA ) National Institute of Allergy and Infectious Diseases ( NIAID ) National Institute of Arthritis and Musculoskeletal and Skin Diseases ( NIAMS ) National Institute of Biomedical Imaging and Bioengineering ( NIBIB ) Eunice Kennedy Shriver National Institute of Child Health and Human National Institute on Deafness and Other Communication Disorders ( NIDCD ) National Institute of Dental and Craniofacial Research ( NIDCR ) National Institute of Diabetes and Digestive and Kidney Diseases ( NIDDK ) National Institute on Drug Abuse ( NIDA ) National Institute of Environmental Health Sciences ( NIEHS ) National Institute of General Medical Sciences ( NIGMS ) National Institute of Mental Health ( NIMH ) National Institute of Neurological Disorders and Stroke ( NINDS ) National Institute of Nursing Research ( NINR ) National Institute on Minority Health and Health Disparities ( NIMHD ) National Library of Medicine ( NLM ) Fogarty International Center ( FIC ) National Center for Complementary and Integrative Health ( NCCIH ) National Center for Advancing Translational Sciences ( NCATS ) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs ( ORIP ) Office of Strategic Coordination ( Common Fund ) Funding Opportunity Title Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Administrative Supplement Additional funds may be awarded as supplements to parent awards using the following Activity Code(s).
Note, however, that not all participating NIH Institutes and Centers (ICs) support all the activity codes listed below.
Applicants must therefore consult the Table of IC-Specific Information, Requirements and Staff Contacts for Administrative supplement requests must be submitted electronically for the following activity codes: DP1 NIH Director’s Pioneer Award (NDPA) DP2 NIH Director’s New Innovator Awards DP4 NIH Director’s Pathfinder Award- Multi-Yr Funding DP5 Early Independence Award G12 Research Centers in Minority Institutions Award G20 Grants for Repair, Renovation and Modernization of Existing Research P01 Research Program Projects P2C Resource-Related Research Multi-Component Projects and Centers P30 Center Core Grants P40 Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Material P41 Biotechnology Resource Grants P51 Primate Research Center Grants PM1 Program Project or Center with Complex Structure PN2 Research Development Center R00 Research Transition Award R01 Research Project Grant R15 Academic Research Enhancement Award (AREA) R18 Research Demonstration and Disseminations Projects R21 Exploratory/Developmental Research Grant Award R21 / R33 Phased Innovation Award R24 Resource-Related Research Projects R33 Exploratory/Developmental Grants Phase II R34 Clinical Trial Planning Grant Program R35 Outstanding Investigator Award R37 Method to Extend Research in Time (MERIT) Award R41 Small Business Technology Transfer (STTR) Grant - Phase I only R41 / R42 Small Business Technology Transfer (STTR) Grant - Phase I, Phase II, and R41 / R42 Small Business Technology Transfer (STTR) Grant - Phase I and Phase II R42 Small Business Technology Transfer (STTR) Grant - Phase II only R43 Small Business Innovation Research (SBIR) Grant - Phase I only R43 / R44 Small Business Innovation Research (SBIR) Grant - Phase I, Phase II, and R43 / R44 Small Business Innovation Research (SBIR) Grant - Phase I and Phase II R44 Small Business Innovation Research (SBIR) Grant - Phase II only R61 / R33 Exploratory/Developmental Phased Award RC1 NIH Challenge Grants and Partnerships Program Phase I RC2 High Impact Research and Research Infrastructure Programs RC3 Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Program RC4 High Impact Research and Research Infrastructure Programs Multi-Yr Funding Multi-Year Funded Research Project RM1 Research Project with Complex Structure SC1 Research-Enhancement Award SC2 Pilot Research Project SC3 Research Continuance Award S06 Minority Biomedical Research Support U01 Research Project Cooperative Agreements U10 Cooperative Clinical Research Cooperative Agreements U13 Conferences Cooperative Agreements U18 Research Demonstration Cooperative Agreements Program Cooperative Agreements Research Projects Cooperative Agreements U34 Clinical Planning Grant Cooperative Agreement U2C Resource-Related Research Multi-Component Projects & Centers UL1 Linked Specialized Center Cooperative Agreement U41 Biotechnology Resource Cooperative Agreements U42 Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Materials Resource Cooperative Agreements U44 Small Business Innovation Research (SBIR) Cooperative Agreements - Phase II U54 Specialized Center- Cooperative Agreements U56 Exploratory Grants Cooperative Agreements UC2 High Impact Research and Research Infrastructure Cooperative Agreement UC4 High Impact Research and Research Infrastructure - Cooperative Agreement Multi-Year Funded Research Project Cooperative Agreement UG1 Clinical Research Cooperative Agreements - Single Project UG3 / UH3 Exploratory/Developmental Phased Award Cooperative Agreement UH2 Exploratory/Developmental Cooperative Agreement Phase I UH2 / UH3 Phase Innovation Awards Cooperative Agreement UH3 Exploratory/Developmental Cooperative Agreement Phase II UM1 Multi-Component Research Project Cooperative Agreements UM2 Program Project or Center with Complex Structure Cooperative Agreement Notices of Special Interest associated with this funding opportunity November 16, 2020 - This PA has been reissued as PA-21-071 .
September 10, 2020 - Reissue of Parent Research Supplements to Promote Diversity in Health-Related Research FOA in October 2020. See Notice NOT-OD-20-170 . August 13, 2020 - Notice to Encourage Eligible NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees to Apply for PA-20-222.
See Notice NOT-NS-20-089 . Funding Opportunity Announcement (FOA) Number Companion Funding Opportunity Additional Information on Eligibility . Catalog of Federal Domestic Assistance (CFDA) Number(s) 93.
113, 93. 121, 93. 172, 93.
173, 93. 213, 93. 242, 93.
273, 93. 279, 93. 286, 93.
307, 93. 310, 93. 350, 93.
351, 93. 361, 93. 398, 93.
837, 93. 839, 93. 838, 93.
233, 93. 840, 93. 846, 93.
847, 93. 853, 93. 859, 93.
865, 93. 866, 93.
867, Funding Opportunity Purpose The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research.
This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.
Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Open Date (Earliest Submission Date) Submission dates vary by awarding IC.
of IC-Specific Information, Requirements and Staff Contacts for Letter of Intent Due Date(s) Due dates vary by awarding IC Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. AIDS Application Due Date(s) Start dates vary by awarding IC.
See Table of IC-Specific Information, Requirements and Staff Contacts for New Date November 30, 2020 per issuance of PA-21-071 .
(Original Expiration Date: May 8, 2023) It is critical that applicants follow the instructions in the Application Guide ( SF424 (R&R) Application Guide , and eRA Commons Administrative Supplement User Guide ) except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts ). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced.
Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV . When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information Part 2. Full Text of the Announcement Section I.
Funding Opportunity Description Section II. Award Information Section III. Eligibility Information Section IV.
Application and Submission Section V. Application Review Information Section VI. Award Administration Information Section VII.
Agency Contacts Section VIII. Other Information Full Text of Announcement Section I.
Funding Opportunity Description of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify all Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding research grants with activity codes listed in "Part 1 Overview Information" that funds are available for administrative supplements to recruit and support high school, undergraduate and graduate/clinical students, postdoctorates (including health professionals), and eligible investigators.
Administrative supplements must support work within the scope of the original provides multiple opportunities to develop research careers and enhance participation for individuals from diverse backgrounds, including those from groups demonstrated to be underrepresented in the biomedical, behavioral, clinical and social sciences. Nevertheless, reports from the National Science Foundation (NSF; see http://www. nsf.
gov/statistics/wmpd/ ) and others provide strong evidence that underrepresentation remains an important problem that the entire research enterprise must actively administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level.
Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce. the proposed research experience must be an integral part of the approved, ongoing research of the parent award, and it must have the potential to contribute significantly to the research career development of the candidate.
in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human of the United States scientific research enterprise from basic laboratory research to clinical and translational research to policy formation requires superior intellect, creativity and a wide range of skill sets and viewpoints.
NIH's ability to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists from diverse backgrounds, including those from underrepresented groups, who will help to further NIH's mission.
to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists including those from underrepresented groups, and others who will help to diversify the workforce to help further NIH’s mission. shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams.
Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems.
There are many benefits that flow from a diverse NIH-supported scientific workforce, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved or health disparity populations participate in, and benefit from health research, and enhancing public trust.
tremendous advancements in scientific research, information, educational and research opportunities are not equally available to all.
NIH encourages institutions to diversify their student, postdoctorate and faculty populations to enhance the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral and social sciences, such as: from racial and ethnic groups that have been shown by the NSF to be underrepresented in health-related sciences on a national basis (see data at http://www. nsf. gov/statistics/showpub.
cfm? TopID=2&SubID=27 ) and the report Women, Minorities, and Persons with Disabilities in Science and Engineering ). The following racial and ethnic groups have been shown to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders.
In addition, it is recognized that underrepresentation can vary from setting to setting; individuals from racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution should be encouraged to participate in this program.
For more information on racial and ethnic categories and definitions, see the OMB Revisions to the Standards for Classification of Federal Data on Race and Ethnicity ( https://www. govinfo. gov/content/pkg/FR-1997-10-30/html/97-28653.
htm ). with disabilities, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities, as described in the Americans with Disabilities Act of 1990, as amended . See NSF data at http://www.
nsf. gov/statistics/wmpd/2013/pdf/tab7-5_updated_2014_10. pdf .
from disadvantaged backgrounds, defined as those who meet two or more of 1. Were or currently are homeless, as defined by the McKinney-Vento Homeless Assistance Act (Definition: https://nche. ed.
gov/mckinney-vento/ ); 2. Were or currently are in the foster care system, as defined by the Administration for Children and Families (Definition: https://www. acf.
hhs. gov/cb/focus-areas/foster-care ); 3. Were eligible for the Federal Free and Reduced Lunch Program for two or more years (Definition: https://www.
fns. usda. gov/school-meals/income-eligibility-guidelines ); 4.
Have/had no parents or legal guardians who completed a bachelor s degree (see https://nces. ed. gov/pubs2018/2018009.
pdf ); 5. Were or currently are eligible for Federal Pell grants (Definition: https://www2. ed.
gov/programs/fpg/eligibility. html ); 6. Received support from the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) as a parent or child (Definition: https://www.
fns. usda. gov/wic/wic-eligibility-requirements ).
7. Grew up in one of the following areas: a) a U.S. rural area, as designated by the Health Resources and Services Administration (HRSA) Rural Health Grants Eligibility Analyzer ( https://data. hrsa.
gov/tools/rural-health ), or b) a Centers for Medicare and Medicaid Services-designated Low-Income and Health Professional Shortage Areas (qualifying zipcodes are included in the file). Only one of the two possibilities in #7 can be used as a criterion for the disadvantaged background definition.
low socioeconomic (SES) status backgrounds have been shown to obtain bachelor s and advanced degrees at significantly lower rates than students from middle and high SES groups (see https://nces. ed. gov/programs/coe/indicator_tva.
asp ), and are subsequently less likely to be represented in biomedical research. For background see Department of Education data at, https://nces. ed.
gov/ ; https://nces. ed. gov/programs/coe/indicator_tva.
asp ; https://www2. ed. gov/rschstat/research/pubs/advancing-diversity-inclusion.
pdf . shows that women from the above backgrounds (categories A, B, and C) face particular challenges at the graduate level and beyond in scientific fields. (See, e.g., From the NIH: A Systems Approach to Increasing the Diversity of Biomedical Research Workforce https://www.
ncbi. nlm. nih.
gov/pmc/articles/PMC5008902/ ).
been shown to be underrepresented in doctorate-granting research institutions at senior faculty levels in most biomedical-relevant disciplines, and may also be underrepresented at other faculty levels in some scientific disciplines (See data from the National Science Foundation National Center for Science and Engineering Statistics: Women, Minorities, and Persons with Disabilities in Science and Engineering, special report available at https://www.
nsf. gov/statistics/2017/nsf17310/ , especially Table 9-23, describing science, engineering, and health doctorate holders employed in universities and 4-year colleges, by broad occupation, sex, years since doctorate, and faculty rank).
NSF data, and scientific discipline or field related data, NIH encourages institutions to consider women for faculty-level, diversity-targeted programs to address faculty recruitment, appointment, retention or advancement. FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial.
Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Information for award authorities and regulations. Section II.
Award Information The funding instrument will be the same as the parent Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity. Cooperative Agreement: A support mechanism used when there will be substantial Federal scientific or programmatic involvement.
Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI. 2 for additional information about the substantial involvement for this FOA.
Application Types Allowed Non-competing Administrative Supplements Not Allowed: Only accepting applications that do not help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations. Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project.
Direct costs for individual administrative supplements vary from less than $5,000 to more than $100,000 depending on the career level of the candidate. Administrative supplements end with the currently funded competitive cycle of the parent grant.
Budget requests may also be limited by the awarding of IC-Specific Information, Requirements and Staff Contacts for The funding mechanism being used to support this program, administrative supplements, can be used to cover cost increases that are associated with achieving certain new research objectives, as long as the research objectives are within the original scope of the peer reviewed and approved project, or the cost increases are for unanticipated expenses within the original scope of the project.
Any cost increases need to result from making modifications to the project that would increase or preserve the overall impact of the project consistent with its originally approved objectives and The project and budget periods must be within the currently approved project period for the existing parent award. NIH grants policies as described Policy Statement will apply to the applications submitted and awards made from this FOA.
All organizations administering an eligible parent award may apply for a supplement under this announcement. This announcement is for supplements to existing projects. To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.
All additional costs must be within the scope of the peer reviewed and approved project. IMPORTANT: The research proposed by the NIH grantee in the supplement application must be within the original scope of the NIH-supported grant Non-domestic (non-U.S.) Entities (Foreign Institutions) are Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement , are allowed. Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. Since administrative supplements are made against active grants and cooperative agreements, many of these registrations may already be in place.
All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
System for Award Management (SAM) Applicants must complete and maintain an active registration, which requires renewal at least annually . The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
Commercial and Government Entity (NCAGE) Code Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. must have an active DUNS number to register in eRA Commons. Organizations can register with the eRA Commons as they are working through their SAM or Grants.
gov registration, but all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application. must have an active DUNS number and SAM registration in order to complete the Grants.
gov registration. Grants. gov registration is only required if you plan to submit using the 'Electronic Application Submission through Grants.
gov' option. Directors/Principal Investigators (PD(s)/PI(s)) All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons.
If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks. Eligible Individuals (Program Director/Principal Individual(s) must be a PD/PI on an active grant or cooperative agreement, and the research proposed in the supplement must be accomplished within the competitive segment of the active award.
For supplements to parent awards that include multiple PDs/PIs, the supplement may be requested by any or all of the PDs/PIs (in accordance with the existing leadership plan) and submitted by the awardee institution of the parent award. Do not use this administrative supplement application to add, delete, or change the PDs/PIs listed on the parent award.
Visit the Multiple Program Director/Principal Investigator Policy in the SF424 (R&R) Application Guide for more information. In addition, subproject directors on multi-component research grants (e.g., P01, P50, U54) may request supplements to their project through the overall PD/PI of the grant.
Established Investigators Who Are or Become Disabled: Established investigators (PDs/PIs) on an NIH research, program project, or center grant who are or become disabled during the current project period may request funds for reasonable accommodations to permit completion of the currently funded research project.
Any currently funded PD(s)/PI(s) on an NIH research project grant, program project grant, or center grant may request support for special equipment, an assistant, or other modifications to facilitate reasonable accommodation to a disabling injury or illness that has occurred during the current project period. This FOA does not require cost sharing as defined in the NIH Grants Policy Statement . 3.
Additional Information on Eligibility award may support more than one individual on a supplement; however, each request must be strongly justified and include assurances that each candidate will receive appropriate mentoring. Investigators are encouraged to recruit more than one high school or undergraduate student for support by a supplemental award.
Appointment of more than one individual to a single award above the high school or undergraduate level depends on the nature of the parent grant, the circumstances of the request, and the program balance of the NIH awarding component. Candidates may receive support from only one administrative supplement at a time, but may be supported by more than one supplement during the development of their research careers.
Support under the supplement is not transferable to another individual or transportable to another institution. Since applications submitted to this announcement will only receive administrative review by the awarding Institute or Center, and will not receive peer review, the NIH policy on resubmission applications will not apply.
However, applications not accepted by the Institute or Center for review, or not funded by the Institute or Center, should not be submitted again without either responding to any written concerns or contacting the awarding Institute or Center for instructions first. Candidates for the Supplement Program purpose of this announcement, institutions are encouraged to identify candidates who will enhance diversity on a national basis.
In addition, it is recognized that underrepresentation can vary from setting to setting; individuals from racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution should be encouraged to participate in this program (see Section I Description).
The strength of an institution's description and justification for the appointment of an identified candidate will be judged along with all other aspects of the proposed experience (see Review Criteria in Section V.
Application Review awards under this announcement are limited to citizens or non-citizen nationals of the United States or to individuals who have been lawfully admitted for permanent residence in the United States (i.e., in possession of a Permanent Resident Card, Form I-551). This program may not be used to provide technical support to NIH-supported investigators.
Note: PD(s)/PI(s) should encourage candidates to submit applications for fellowships, career development awards, research grants, and other sources of independent support before the supplement period ends.
are encouraged to consider administrative supplements under this program for candidates at the following career levels: School Students: The purpose of this program is to provide high school students who have expressed an interest in the health-related sciences with an opportunity to obtain a meaningful experience in health-related research to stimulate their interest in research careers in biomedical, behavioral, clinical or social sciences.
Any eligible high school student who is currently enrolled and in good standing at her or his high school and is interested in these areas of science is encouraged to participate Students: As part of this supplement program, undergraduate students with a demonstrated interest in or desire to pursue research training in health-related sciences, may participate in a research project during the summer months and/or the academic year.
This experience is separate from any requirement of the regular academic program. The student may be affiliated with either the applicant institution or another academic institution. Any eligible undergraduate student interested in health-related research is encouraged to participate in this program.
and Master's Degree Holders: This supplement will provide opportunities for baccalaureate or master's degree holders who have demonstrated an interest in and wish to pursue research training in health-related sciences while applying for admission to graduate or medical school.
The duration of the program is normally 1 year, but the research experience can be extended for an additional year if evidence is provided to show that the candidate is actively pursuing entry into a graduate or a health professions school. Students who plan to attend medical, dental or other professional schools are encouraged to use this program to gain research experience.
(Predoctoral) and Health Professional Students: The objective of this program is to support graduate/health professional (e.g., PhD, MD, DDS, DVM, etc.) students in biomedical, behavioral, clinical or social sciences, and health professional students who wish to develop their research capabilities.
However, because this program is not intended to provide an alternative or additional means of supporting individuals who receive support from an NIH research grant, a Ruth L.
Kirschstein National Research Service Award (Kirschstein-NRSA), or any other PHS funding mechanism, students who are supported by an institutional Kirschstein-NRSA may not be transferred to supplemental support prior to the completion of their appointed period of training. In addition, individuals may not be transferred to a supplement to increase the availability of funds to the parent grant for other uses.
Individuals may be supported by the parent grant for short periods, at the recipient’s risk, pending Institute/Center decision on the supplement application. (See Pre-Award (Pre-Agreement) Costs in the Section 7. 9.
1 of the NIH Grants Policy Statement for further information). in Postdoctoral Training: These supplements support individuals in the postdoctoral research phase of their training who wish to participate as researchers in ongoing research projects and career development experiences in preparation for an independent career in health-related research.
This experience must serve as a means of assisting the postdoctoral researcher's development into a productive researcher in health-related science.
Because this program is not intended to provide an alternative or additional means of supporting individuals who receive support from PHS funding mechanisms, individuals in postdoctoral training who are supported by an institutional Kirschstein-NRSA may not be transferred to supplemental support prior to the completion of their appointed period of training.
In addition, individuals may not be transferred to a supplement to increase the availability of funds to the parent grant for other uses. Individuals may be supported by the parent grant for short periods, at the recipient’s risk, pending Institute/Center decision on the supplement application. (See Pre-Award (Pre-Agreement) Costs in the Section 7.
9. 1 of the NIH Grants Policy Statement for further information). The individual in postdoctoral training may be affiliated with either the applicant institution or some other institution.
Only under extraordinary circumstances, which must be well justified in the application, would it be acceptable for the postdoctoral candidate to work with his/her former Developing Independent Research Careers: These supplements provide either short or long-term research support for faculty members who wish to participate in ongoing research projects while further developing their own research potential, to enhance their research skills and establish an independent research career.
Investigator Research Supplement: This supplement provides short-term support for faculty members to conduct full-time research in the biomedical, behavioral, clinical or social sciences for three to five months each year during the summer or another portion of the academic year, over a maximum period of four years.
Long-term Investigator Research Supplement: This supplement provides long-term research support for faculty members to conduct research in the biomedical, behavioral, clinical or social sciences. Support is usually provided for up to two years at a minimum of 9 person months (equivalent to 75% effort) during each 12-month period.
case (1 or 2 above), the investigator may be affiliated with the applicant institution or some other institution. The investigator must have a doctoral degree, be beyond the level of a research trainee (post-residency and specialty training), typically employed at the junior faculty level (instructor or assistant professor) with at least one year of postdoctoral or equivalent research experience.
An individual who has received previous funding from NIH as an independent PD/PI on a research grant (e.g., R01), as the project leader on a component of a program project or center grant (e.g., P01, P50, G12), or as PD/PI on an individual research career development award (e.g., K01, K02, K07, K08, and K23), is not eligible.
However, individuals appointed as Scholars on Institutional Career Development Award (K12, KL2) are eligible for this supplement program. awards, see the listing of Activity Codes under "Part 1. Overview Information."
Note however that not all participating components support all the activity codes listed in this FOA. PD(s)/PI(s) who hold an active grant or cooperative agreement may be eligible to submit a request for an administrative supplement to the awarding component of the parent
According to the current listing, eligibility includes: Principal Investigators (PIs) of active parent awards from specific NIGMS programs (e. g. , SuRE (R16), COBRE (P20), IDeA-CTR (U54), INBRE (P20), NARCH (S06)) are eligible. Confirm the full requirements in the official notice before applying.
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Optional) (PA-20-272) is funded by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Commercialization Readiness Pilot (CRP) Program (PAR-27-098) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). This program facilitates the transition of previously funded SBIR and STTR Phase 2 and Phase 2B projects to the commercialization stage by providing additional support for technical assistance and late-stage product development.
NIH Small Business Innovation Research (SBIR) Program (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-24-245) / (Parent SBIR [R43/R44] Clinical Trial Required) (PA-24-246) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). NIGMS participates in the NIH SBIR program, which supports small businesses engaging in research and development activities with strong potential for commercialization.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) / National Institute of General Medical Sciences (NIGMS). This omnibus solicitation supports small businesses engaged in research and development with strong commercialization potential, addressing challenges faced by NIH populations experiencing health disparities. This includes technology and service innovations.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleAfter a rare gap with zero active omnibus NOFOs, NIH has reissued its SBIR/STTR parent announcements — collapsing four solicitations into two, adding a Strategic Breakthrough bridge and a Commercialization Readiness Pilot, and reopening the funnel with a September 5, 2026 receipt date. Here are the exact solicitation numbers, the new budget ceilings, what actually changed, and how a small business should sequence its submission.
Read articleAfter an authorization lapse froze new SBIR/STTR awards for five months, NIH reopens its submission window on August 5, 2026, with a first standard deadline of September 8. Phase I awards run to $323,090, Phase II to $2,153,927, with published waiver topics reaching $700,000 and $3 million — and a new Phase IIB Strategic Breakthrough lane up to $30 million. Here is how the restarted omnibus is structured, why applying early matters more than usual this cycle, and how to position a life-science startup to win.
Read article